wow! Adult stem cells injected directly into brains of 18 chronic stroke patients one year after their strokes allowed for major improvements. Small study at Stanford with a new study now recruiting stroke patients.
Interestingly, the stem cells were not autologous, but were SB623 cells manufactured and provided by SanBio Inc., a biotechnology company based in Mountain View, California. ("SanBio also funded and helped in designing the trial, but did not participate in its execution." Wonder if this means the FDA would
l be more likely approve of this procedure, since it can be patented and monetized.) Still, it's reason for hope.

“This could revolutionize our concept of what happens after not only stroke, but traumatic brain injury and even neurodegenerative disorders. The notion was that once the brain is injured, it doesn’t recover — you’re stuck with it. But if we can figure out how to jump-start these damaged brain circuits, we can change the whole effect.

“We thought those brain circuits were dead. And we’ve learned that they’re not.”

A new randomized, double-blinded multicenter phase-2b trial aiming to enroll 156 chronic stroke patients is now actively recruiting patients. Steinberg is the principal investigator of that trial. For more information, please e-mail stemcellstudy@stanford.edu. http://med.stanford.edu/news/all-news/2016/06/stem-cells-shown-safe-beneficial-for-chronic-stroke-patients.html

People disabled by a stroke demonstrated substantial recovery long after the event when modified adult stem cells were injected into their brains.